aluates Reports

$ 0.0

Automative

Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-2P18165

BUY CHAPTERS

Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Research Report 2024

Code: QYRE-Auto-2P18165

Report

August 2024

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

NRG

NTP Radioisotopes

JSC Isotope

ANSTO

China National Nuclear Corporation (CNNC)

IRE ELiT

Nordion

Polatom

Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market

The global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Radioisotopes for Nuclear Medicine Diagnosis and Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Radioisotopes for Nuclear Medicine Diagnosis and Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Radioisotopes for Nuclear Medicine Diagnosis and Treatment in Nuclear Medicine Diagnosis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Radioisotopes for Nuclear Medicine Diagnosis and Treatment include NRG, NTP Radioisotopes, JSC Isotope, ANSTO, China National Nuclear Corporation (CNNC), IRE ELIT, Nordion, Polatom, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Radioisotopes for Nuclear Medicine Diagnosis and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioisotopes for Nuclear Medicine Diagnosis and Treatment.

The Radioisotopes for Nuclear Medicine Diagnosis and Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Radioisotopes for Nuclear Medicine Diagnosis and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Radioisotopes for Nuclear Medicine Diagnosis and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Report

Report Metric	Details
Report Name	Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market
Segment by Type	Carbon-14 Technetium-99m Iodine-131 Iodine-125 Others
Segment by Application	Nuclear Medicine Diagnosis Nuclear Medicine Treatment Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	NRG, NTP Radioisotopes, JSC Isotope, ANSTO, China National Nuclear Corporation (CNNC), IRE ELIT, Nordion, Polatom
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radioisotopes for Nuclear Medicine Diagnosis and Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market report?

Ans: The main players in the Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market are NRG, NTP Radioisotopes, JSC Isotope, ANSTO, China National Nuclear Corporation (CNNC), IRE ELIT, Nordion, Polatom

What are the Application segmentation covered in the Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market report?

Ans: The Applications covered in the Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market report are Nuclear Medicine Diagnosis, Nuclear Medicine Treatment, Others

What are the Type segmentation covered in the Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market report?

Ans: The Types covered in the Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market report are Carbon-14, Technetium-99m, Iodine-131, Iodine-125, Others

Recommended Reports

Nuclear Medicine Devices

Radioisotopes & Radiopharmaceuticals

Cancer Diagnostics & Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Carbon-14

1.2.3 Technetium-99m

1.2.4 Iodine-131

1.2.5 Iodine-125

1.2.6 Others

1.3 Market by Application

1.3.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Nuclear Medicine Diagnosis

1.3.3 Nuclear Medicine Treatment

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Perspective (2019-2030)

2.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Growth Trends by Region

2.2.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Historic Market Size by Region (2019-2024)

2.2.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Region (2025-2030)

2.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Dynamics

2.3.1 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Industry Trends

2.3.2 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Drivers

2.3.3 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Challenges

2.3.4 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players by Revenue

3.1.1 Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players by Revenue (2019-2024)

3.1.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue

3.4 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Concentration Ratio

3.4.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue in 2023

3.5 Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment Head office and Area Served

3.6 Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Product and Application

3.7 Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Breakdown Data by Type

4.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Historic Market Size by Type (2019-2024)

4.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Type (2025-2030)

5 Radioisotopes for Nuclear Medicine Diagnosis and Treatment Breakdown Data by Application

5.1 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Historic Market Size by Application (2019-2024)

5.2 Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2019-2030)

6.2 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2019-2024)

6.4 North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2019-2030)

7.2 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2019-2024)

7.4 Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2019-2030)

8.2 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2019-2030)

9.2 Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2019-2024)

9.4 Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (2019-2030)

10.2 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 NRG

11.1.1 NRG Company Details

11.1.2 NRG Business Overview

11.1.3 NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction

11.1.4 NRG Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024)

11.1.5 NRG Recent Development

11.2 NTP Radioisotopes

11.2.1 NTP Radioisotopes Company Details

11.2.2 NTP Radioisotopes Business Overview

11.2.3 NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction

11.2.4 NTP Radioisotopes Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024)

11.2.5 NTP Radioisotopes Recent Development

11.3 JSC Isotope

11.3.1 JSC Isotope Company Details

11.3.2 JSC Isotope Business Overview

11.3.3 JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction

11.3.4 JSC Isotope Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024)

11.3.5 JSC Isotope Recent Development

11.4 ANSTO

11.4.1 ANSTO Company Details

11.4.2 ANSTO Business Overview

11.4.3 ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction

11.4.4 ANSTO Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024)

11.4.5 ANSTO Recent Development

11.5 China National Nuclear Corporation (CNNC)

11.5.1 China National Nuclear Corporation (CNNC) Company Details

11.5.2 China National Nuclear Corporation (CNNC) Business Overview

11.5.3 China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction

11.5.4 China National Nuclear Corporation (CNNC) Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024)

11.5.5 China National Nuclear Corporation (CNNC) Recent Development

11.6 IRE ELIT

11.6.1 IRE ELIT Company Details

11.6.2 IRE ELIT Business Overview

11.6.3 IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction

11.6.4 IRE ELIT Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024)

11.6.5 IRE ELIT Recent Development

11.7 Nordion

11.7.1 Nordion Company Details

11.7.2 Nordion Business Overview

11.7.3 Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction

11.7.4 Nordion Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024)

11.7.5 Nordion Recent Development

11.8 Polatom

11.8.1 Polatom Company Details

11.8.2 Polatom Business Overview

11.8.3 Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Introduction

11.8.4 Polatom Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024)

11.8.5 Polatom Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

NRG

NTP Radioisotopes

JSC Isotope

ANSTO

China National Nuclear Corporation (CNNC)

IRE ELiT

Nordion

Polatom

List of Tables

Table 1. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Carbon-14

Table 3. Key Players of Technetium-99m

Table 4. Key Players of Iodine-131

Table 5. Key Players of Iodine-125

Table 6. Key Players of Others

Table 7. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Region (2019-2024)

Table 11. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Region (2025-2030)

Table 13. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Trends

Table 14. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Drivers

Table 15. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Challenges

Table 16. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Restraints

Table 17. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Players (2019-2024)

Table 19. Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment as of 2023)

Table 20. Ranking of Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Headquarters and Area Served

Table 23. Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Product and Application

Table 24. Global Key Players of Radioisotopes for Nuclear Medicine Diagnosis and Treatment, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Type (2019-2024)

Table 28. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Type (2025-2030)

Table 30. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Application (2019-2024)

Table 32. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue Market Share by Application (2025-2030)

Table 34. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 49. NRG Company Details

Table 50. NRG Business Overview

Table 51. NRG Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product

Table 52. NRG Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024) & (US$ Million)

Table 53. NRG Recent Development

Table 54. NTP Radioisotopes Company Details

Table 55. NTP Radioisotopes Business Overview

Table 56. NTP Radioisotopes Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product

Table 57. NTP Radioisotopes Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024) & (US$ Million)

Table 58. NTP Radioisotopes Recent Development

Table 59. JSC Isotope Company Details

Table 60. JSC Isotope Business Overview

Table 61. JSC Isotope Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product

Table 62. JSC Isotope Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024) & (US$ Million)

Table 63. JSC Isotope Recent Development

Table 64. ANSTO Company Details

Table 65. ANSTO Business Overview

Table 66. ANSTO Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product

Table 67. ANSTO Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024) & (US$ Million)

Table 68. ANSTO Recent Development

Table 69. China National Nuclear Corporation (CNNC) Company Details

Table 70. China National Nuclear Corporation (CNNC) Business Overview

Table 71. China National Nuclear Corporation (CNNC) Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product

Table 72. China National Nuclear Corporation (CNNC) Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024) & (US$ Million)

Table 73. China National Nuclear Corporation (CNNC) Recent Development

Table 74. IRE ELIT Company Details

Table 75. IRE ELIT Business Overview

Table 76. IRE ELIT Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product

Table 77. IRE ELIT Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024) & (US$ Million)

Table 78. IRE ELIT Recent Development

Table 79. Nordion Company Details

Table 80. Nordion Business Overview

Table 81. Nordion Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product

Table 82. Nordion Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024) & (US$ Million)

Table 83. Nordion Recent Development

Table 84. Polatom Company Details

Table 85. Polatom Business Overview

Table 86. Polatom Radioisotopes for Nuclear Medicine Diagnosis and Treatment Product

Table 87. Polatom Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024) & (US$ Million)

Table 88. Polatom Recent Development

Table 89. Research Programs/Design for This Report

Table 90. Key Data Information from Secondary Sources

Table 91. Key Data Information from Primary Sources

Table 92. Authors List of This Report

List of Figures

Figure 1. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Picture

Figure 2. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Type: 2023 VS 2030

Figure 4. Carbon-14 Features

Figure 5. Technetium-99m Features

Figure 6. Iodine-131 Features

Figure 7. Iodine-125 Features

Figure 8. Others Features

Figure 9. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size by Application (2024-2030) & (US$ Million)

Figure 10. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Application: 2023 VS 2030

Figure 11. Nuclear Medicine Diagnosis Case Studies

Figure 12. Nuclear Medicine Treatment Case Studies

Figure 13. Others Case Studies

Figure 14. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Report Years Considered

Figure 15. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Region: 2023 VS 2030

Figure 18. Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Players in 2023

Figure 19. Global Top Radioisotopes for Nuclear Medicine Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioisotopes for Nuclear Medicine Diagnosis and Treatment as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Radioisotopes for Nuclear Medicine Diagnosis and Treatment Revenue in 2023

Figure 21. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Country (2019-2030)

Figure 23. United States Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Country (2019-2030)

Figure 27. Germany Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Region (2019-2030)

Figure 35. China Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Country (2019-2030)

Figure 43. Mexico Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Share by Country (2019-2030)

Figure 47. Turkey Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. UAE Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. NRG Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024)

Figure 51. NTP Radioisotopes Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024)

Figure 52. JSC Isotope Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024)

Figure 53. ANSTO Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024)

Figure 54. China National Nuclear Corporation (CNNC) Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024)

Figure 55. IRE ELIT Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024)

Figure 56. Nordion Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024)

Figure 57. Polatom Revenue Growth Rate in Radioisotopes for Nuclear Medicine Diagnosis and Treatment Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.